Invention Grant
- Patent Title: Synthetic human immunodeficiency virus (HIV) envelope antigen, vectors, and compositions thereof
-
Application No.: US15380123Application Date: 2016-12-15
-
Publication No.: US10369214B2Publication Date: 2019-08-06
- Inventor: Johannes Petrus Maria Langedijk , Danielle Van Manen , Jort Vellinga , Frank Wegmann , Benoit Christophe Stephan Callendret , Anders Krarup , Jörn Stitz
- Applicant: Janssen Vaccines & Prevention B.V.
- Applicant Address: NL Leiden
- Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee Address: NL Leiden
- Agency: Panitch Schwarze Belisario & Nadel LLP
- Priority: EP15200138 20151215; EP16194124 20161017
- Main IPC: A61K39/21
- IPC: A61K39/21 ; C07K14/16 ; C07K14/005 ; C12N7/00 ; C12N15/86 ; C12N15/861 ; A61K39/00

Abstract:
Synthetic HIV envelope proteins, vectors and compositions thereof, and methods for inducing protective immunity against human immunodeficiency virus (HIV) infection are described. Viral expression vectors encoding the synthetic HIV envelope proteins can be used in vaccines to provide improved protective immunity against HIV.
Public/Granted literature
- US20170165355A1 HUMAN IMMUNODEFICIENCY VIRUS ANTIGENS, VECTORS, COMPOSITIONS, AND METHODS OF USE THEREOF Public/Granted day:2017-06-15
Information query